HealthQuest Capital is a growth capital firm based in the San Francisco Bay Area, specializing in investing in commercial-stage companies that are transforming healthcare by improving patient outcomes and reducing costs. Founded in 2013 by Dr. Garheng Kong, the firm manages approximately $2 billion in assets across multiple funds.

HealthQuest Capital focuses on fostering innovation across the healthcare spectrum, including medical technologies, diagnostics, digital health, and innovative services. The team combines decades of successful investing experience with deep domain expertise in all aspects of the healthcare industry. Notable investments include Everly Health, Lunit, Thirty Madison, and TigerConnect.

The firm has also seen 18 exits across IPOs and M&A transactions, including the sale of BardyDx to Hillrom (now Baxter), BioIQ to LetsGetChecked, Biotheranostics to Hologic, and the IPO of Castle Biosciences.